1. |
- Herlitz, Johan, et al.
(författare)
-
Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction
- 1988
-
Ingår i: Journal of Internal Medicine. - : Wiley-Blackwell Publishing Ltd.. - 0954-6820 .- 1365-2796. ; 224:1, s. 31-38
-
Tidskriftsartikel (refereegranskat)abstract
- In 787 patients with acute myocardial infarction originally participating in the Göteborg Metoprolol Trial, mortality and morbidity during 5 years' follow-up were assessed and related to whether patients had diabetes mellitus. Diabetes occurred in 78 patients (10%). Patients with diabetes had a different risk factor pattern, including higher age, higher occurrence of angina pectoris and hypertension, whereas smoking habits did not differ. In the early phase (hospitalization), patients with diabetes had a higher mortality (12% versus 8%), required more treatment for heart failure and stayed longer in hospital. Other morbidity aspects, such as severity of pain, occurrence of severe supraventricular and ventricular arrhythmias, high-degree AV-block and infarct size did not differ. During 5 years' follow-up mortality rate in patients with diabetes mellitus was 55% as compared with 30% among patients with no diabetes (P<0.001). Reinfarction rate during 5 years was 42% in daibetics versus 25% in non-diabetics (P<0.001). In a multivariate analysis, taking into account the differences in risk factor pattern, diabetes turned out to be an independent determinant for long-term mortality and reinfarction (P<0.001). We conclude that patients with diabetes mellitus, developing acute myocardial infarction, is a group with particularly high risk of death and reinfarction. Interventions aiming at its reduction have priority.
|
|
2. |
|
|
3. |
|
|
4. |
|
|
5. |
- Herlitz, Johan, et al.
(författare)
-
Body temperature in acute myocardial infarction and its relation to early intervention with metoprolol
- 1988
-
Ingår i: International Journal of Cardiology. - : Elsevier Ireland Ltd. - 0167-5273 .- 1874-1754. ; 20:1, s. 65-71
-
Tidskriftsartikel (refereegranskat)abstract
- In a subsample of 223 patients participating in a double-blind trial with metoprolol in suspected acute myocardial infarction, body temperature during the first 5 days in hospital was recorded. Patients developing infarction had a mean temperature of 37.3°C compared with 36.8° C for those with no infarction (P < 0.001). A positive association was observed between enzyme-estimated infarct size and body temperature (P < 0.001). Patients given metoprolol had a mean temperature of 37.0° C as compared with 37.2° C in those given placebo (P = 0.03). The most marked difference between metoprolol and placebo was observed among those treated very early. We conclude that early treatment with metoprolol in suspected acute myocardial infarction appears to lower body temperature during the following days. This might reflect limitation of the infarct size.
|
|
6. |
- Herlitz, Johan, et al.
(författare)
-
Clinical observations after treatment with metoprolol in suspected acute myocardial infarction in relation to age
- 1985
-
Ingår i: Acta Medica Scandinavica. - : Wiley-Blackwell Publishing Ltd.. - 0001-6101. ; 217:3, s. 293-298
-
Tidskriftsartikel (refereegranskat)abstract
- A double-blind trial with the beta 1-selective blocker metoprolol in suspected acute myocardial infarction and during 3 months' follow-up included 1395 patients, aged 40-74 years, 698 on metoprolol and 697 on placebo. In order to further evaluate the tolerability to beta-blockade in the elderly, the total series was divided into 2 groups according to median age (61 years) and into quartiles, the lowest quartile (40-57 years) being compared with the highest (67-74 years). The decrease in heart rate and systolic blood pressure after intravenous metoprolol in the acute phase was similar in the elderly and the younger patients. Hypotension was observed more often in the metoprolol-treated than in the placebo-treated younger patients, while no difference was observed in the elderly. Bradycardia was observed more often in the metoprolol group in both age groups, while there was no difference regarding the incidence of congestive heart failure in either the younger or in the elderly patients. The effect on mortality, serious ventricular arrhythmias and chest pain seemed to be similar in different age groups. From the present series we conclude that hemodynamic reactions and tolerability to beta-blockade can be expected to be similar in elderly and younger patients.
|
|
7. |
- Herlitz, Johan, et al.
(författare)
-
Effect of media campaign on delay times and ambulance use in suspected acut myocardial infarction
- 1989
-
Ingår i: American Journal of Cardiology. - : Excerpta Medica, Inc.. - 0002-9149 .- 1879-1913. ; 64:1, s. 90-93
-
Tidskriftsartikel (refereegranskat)abstract
- The early phase in suspected acute myocardial infarction (AMI) is particularly critical. More than 50% of deaths from coronary artery disease occur outside the hospital mainly due to ventricular fibrillation.1 Recent experiences strongly indicate that early intervention with thrombolysis2–4 and β blockers5,6 can limit myocardial damage and thereby improve prognosis. Delay times in suspected AMI have remained stable over the years. Therefore, a media campaign was started in the urban area of Göteborg, Sweden, with the intention to shorten delay times and to increase ambulance use in patients with suspected AMI.
|
|
8. |
- Herlitz, Johan, et al.
(författare)
-
Effects on mortality during five years follow-up after early intervention with metoprolol in suspected acute myocardial infarction
- 1988
-
Ingår i: Acta Medica Scadinavica. - : Wiley-Blackwell. - 0001-6101. ; 223:3, s. 227-231
-
Tidskriftsartikel (refereegranskat)abstract
- This study reports the mortality over a 5-year-period determined a double-blind trial, which evaluated the effect of early intervention with metoprolol in suspected acute myocardial infarction. In all, there were 1,395 randomized patients, 698 and 697 of whom were allocated to metoprolol 200 mg daily and placebo treatments, respectively, for the first 3 months. Thereafter, the two groups were treated in a similar fashion implying beta-blockade to a majority. Within the first 3 months, mortality in the metoprolol group was 5.7% versus 8.9% of the placebo group (p = 0.02). This difference persisted after 2 years (metoprolol 13.2%; placebo 17.2%; p = 0.04). Over a 5-year-period, 24.2% of the patients who originally were allocated to metoprolol had died as compared to 25.7% of those originally allocated to placebo (p greater than 0.2). Among patients in whom treatment started early (less than or equal to 8 hours after onset of pain = the median delay time), enzyme activities in the metoprolol group was lower (p = 0.03) than in the placebo group. Mortality during the first 2 years among these patients treated early was lower in the metoprolol (11.8%) than in the placebo group (17.3%; p = 0.04). Corresponding figures after 5 years were 22.0% and 25.3%, respectively (p greater than 0.2). Among patients in whom treatment started later than 8 hours onset of pain, there was neither any difference in enzyme activity nor in mortality after 2 and 5 years. It can be concluded that early treatment with metoprolol in suspected acute myocardial infarction reduced mortality during the first 3 months compared with placebo. The difference persisted after 2 years. However, 5 years after randomization, no significant difference in mortality was observed between the two treatment groups.
|
|
9. |
- Herlitz, Johan, et al.
(författare)
-
Experiences from the use of twenty-four precordial chest leads in suspected acute myocardial infarction
- 1986
-
Ingår i: Journal of Electrocardiology. - : Churchill Livingstone. - 0022-0736 .- 1532-8430. ; 19:4, s. 381-388
-
Tidskriftsartikel (refereegranskat)abstract
- In 671 patients with suspected acute myocardial infarction (MI) and no previous MI, precordial mapping with a grid containing 24 chest leads was performed within a few hours (mean = 4.8 hours; range 0-42 hours) after arrival in hospital and four days later. In 76% of the patients the criteria for definite MI, based on serum enzymes and a 12 lead standard electrocardiogram, were fulfilled. Among patients classified as having no definite MI, 2% had abnormal Q-waves on mapping on the fourth day; among patients classified as having a subendocardial MI (no abnormal Q-waves in the 12 standard leads), 7% had abnormal Q-waves on mapping on the fourth day. In patients who subsequently developed anterior MI, changes in the sum of Q-waves and the sum of R-waves were observed for more than 12 hours after onset of pain. ST-elevations defined from a normal population were seen in the initial recording in 60% of patients with anterior MI. Among those in whom the first recording was performed less than or equal to 4 hours after onset of pain, ST elevation was initially seen in 72%. A positive correlation was observed between the initial ST elevation and severity of chest pain, incidence of congestive heart failure and two-year mortality rate. We thus conclude that some further information regarding presence of Q-waves can be obtained in about 5% of patients with suspected acute MI from an increased number of precordial leads.
|
|
10. |
|
|